Clinical Trials Logo

Clinical Trial Summary

The target population for our study is healthy nulliparous pregnant women (first pregnancy) between the 12-16 week of pregnancy. If a subject is eligible, written consent will be obtained by person to person contact. Eligible participants will be randomized to receive either daily L-citrulline supplementation or placebo.


Clinical Trial Description

Healthy nulliparous pregnant women (first pregnancy) between the 12-16 week of pregnancy will be eligible for this study. The purpose of this study will be to determine if daily supplementation of oral L-citrulline can reduce the incidence of pregnancy induced hypertension. This will be a double blind study, subjects will be randomized to receive either L-citrulline (3 gram sachet) or a placebo for a total of 8 weeks. Participants will be asked to provide urine and blood samples at time of enrollment, be asked to respond to a phone survey to assess for side effects, and again be asked to provide urine and blood samples at the end of 8 weeks. Participants will continue with routine prenatal care throughout the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04979793
Study type Interventional
Source The University of Texas Medical Branch, Galveston
Contact
Status Suspended
Phase Phase 1
Start date July 28, 2021
Completion date July 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT02384226 - User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
Completed NCT02148965 - Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial N/A
Completed NCT03215173 - Fit After Baby: Increasing Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease N/A
Completed NCT03323762 - Effect of RIC on BP and Inflammatory Response in Women With Pre-eclampsia N/A
Recruiting NCT04604535 - The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy N/A
Recruiting NCT02920593 - A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Phase 4
Recruiting NCT04877119 - sFlt-1:PlGF Ratio in Gestational Diabetes: PREDICTION (PREeclampsia in DIabetiC gestaTION) Study
Recruiting NCT05773677 - Diet in Twin Pregnancy: the Wellness of Mother and Babies. N/A
Completed NCT04119232 - Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy N/A
Completed NCT05595629 - App-based Remote Blood Pressure Monitoring N/A
Completed NCT05542654 - The Effect of Foot Massage on Blood Pressure and Anxiety Levels in Pregnants With Hypertension N/A
Recruiting NCT03298802 - Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide Phase 3
Completed NCT03922087 - No-worry Baby Project
Recruiting NCT06069102 - Optimal Blood Pressure Treatment Thresholds Postpartum Phase 4
Recruiting NCT05888467 - Physical Activity and Cardiovascular Profile of Pre-conceptional Women at Risk for GHD N/A
Not yet recruiting NCT03930693 - Role of the Oral Microbiome in Blood Pressure Regulation in Pregnancy Early Phase 1
Not yet recruiting NCT06281665 - Treatment With Aspirin After Preeclampsia: TAP Trial Phase 4
Not yet recruiting NCT06320054 - Preventing Obstetric Complications With Dietary Intervention N/A
Not yet recruiting NCT06123377 - Angiogenic Factors in the Conservative Management of Gestational Hypertension N/A
Completed NCT05124327 - Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy N/A